Sucralfate
Brand name: Sucralfate
Rank #258 of 500 drugs by total cost
$48.5M
Total Cost
689,007
Total Claims
$48.5M
Total Cost
22,924
Prescribers
$70
Cost per Claim
147,545
Beneficiaries
906,110
30-Day Fills
$2,115
Avg Cost/Provider
30
Avg Claims/Provider
About Sucralfate
Sucralfate (sold as Sucralfate) was prescribed 689,007 times by 22,924 Medicare Part D providers in 2023, costing the program $48.5M. At $70 per claim, this is a relatively affordable medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 255 | Diclofenac Epolamine (Licart) | $50.5M | 72,299 |
| 256 | Donepezil Hcl (Donepezil Hcl) | $50.3M | 3,178,215 |
| 257 | Paliperidone (Paliperidone Er) | $49.3M | 129,516 |
| 258 | Sucralfate (Sucralfate) | $48.5M | 689,007 |
| 259 | Diroximel Fumarate (Vumerity) | $48.5M | 5,351 |
| 260 | Cabotegravir/Rilpivirine (Cabenuva) | $48.1M | 7,384 |
| 261 | Cenobamate (Xcopri) | $47.6M | 33,831 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology